Solutions...

Pricing & Access
Strategies

Optimal pricing strategies for development decisions and market access.

Read more

Conjoint
Research

Delivering conjoint that can handle the intricacies of the pharma market.

Read more

Forecasting
Software

Allowing leading pharma companies to build evidence-based forecasts fast and easily.

Read more

Launch Sequence
Simulators

Get your country launch sequence right. Capture full value in the face of international reference pricing.

Read more

Training
Courses

Industry-leading pricing-for-market-access and forecasting training.

Read more

Speaking to just a handful of payers risks your pricing strategy suffering from unreliable, wide-ranging price responses. Pricing strategies rely on quantitative metrics, and quantitative metrics must be powered with reliable respondent sample sizes. However, payers can be difficult to recruit into research projects, especially outside of the US. This article investigates what constitutes a reliable payer sample.